Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia

被引：0
|
作者：
Karlo Perica
Jessica Flynn
Kevin J. Curran
Isabelle Rivere
Xiuyan Wang
Brigitte Senechal
Elizabeth Halton
Claudia Diamonte
John Pineda
Yvette Bernal
Mithat Gonen
Michel Sadelain
Renier J. Brentjens
Jae H. Park
机构：
[1] Cellular Therapy Center,Department of Medicine
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology & Biostatistics
来源：
Leukemia | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3268 / 3271
页数：3
相关论文
共 50 条
  • [41] CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study
    Guoqing Wei
    Yongxian Hu
    Chengfei Pu
    Jian Yu
    Yi Luo
    Jimin Shi
    Qu Cui
    Wenjun Wu
    Jinping Wang
    Lei Xiao
    Zhao Wu
    He Huang
    Annals of Hematology, 2018, 97 : 781 - 789
  • [42] CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study
    Wei, Guoqing
    Hu, Yongxian
    Pu, Chengfei
    Yu, Jian
    Luo, Yi
    Shi, Jimin
    Cui, Qu
    Wu, Wenjun
    Wang, Jinping
    Xiao, Lei
    Wu, Zhao
    Huang, He
    ANNALS OF HEMATOLOGY, 2018, 97 (05) : 781 - 789
  • [43] ACUTE KIDNEY INJURY AFTER CD19-TARGETED CAR T CELL THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Myers, Regina
    Fitzgerald, Julie
    Elgarten, Caitlin
    Getz, Kelly
    Li, Yimei
    Hogan, Jonathan
    DiNofia, Amanda
    Burrows, Evanette
    Fisher, Brian
    Aplenc, Richard
    Grupp, Stephen
    Laskin, Benjamin
    Maude, Shannon
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [44] CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
    Li-Na Zhang
    Yongping Song
    Delong Liu
    Journal of Hematology & Oncology, 11
  • [45] CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study
    Hu, Y.
    Yu, J.
    Wu, Z.
    Luo, Y.
    Shi, J.
    Xiao, L.
    Huang, H.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S57 - S58
  • [46] Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation
    Liu, Shuangyou
    Deng, Biping
    Yin, Zhichao
    Lin, Yuehui
    An, Lihong
    Liu, Dan
    Pan, Jing
    Yu, Xinjian
    Chen, Bingzhen
    Wu, Tong
    Chang, Alex H.
    Tong, Chunrong
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (06) : 671 - 679
  • [47] CD19 CAR T-CELL CLINICAL OUTCOME IS ASSOCIATED WITH THE GUT MICROBIOME
    不详
    CANCER DISCOVERY, 2022, 12 (05) : 1182 - 1182
  • [48] Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy
    Chen, Man
    Fu, Minjing
    Wang, Aixian
    Wu, Xueying
    Zhen, Junyi
    Gong, Meiwei
    Zhang, Xian
    Yue, Guanlan
    Du, Qing
    Zhao, Wei
    Zhao, Yanli
    Lu, Peihua
    Wang, Hui
    LEUKEMIA & LYMPHOMA, 2022, 63 (02) : 426 - 434
  • [49] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [50] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Runxia Gu
    Fang Liu
    Dehui Zou
    Yingxi Xu
    Yang Lu
    Bingcheng Liu
    Wei Liu
    Xiaojuan Chen
    Kaiqi Liu
    Ye Guo
    Xiaoyuan Gong
    Rui Lv
    Xia Chen
    Chunlin Zhou
    Mengjun Zhong
    Huijun Wang
    Hui Wei
    Yingchang Mi
    Lugui Qiu
    Lulu Lv
    Min Wang
    Ying Wang
    Xiaofan Zhu
    Jianxiang Wang
    Journal of Hematology & Oncology, 13
12345